πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated β€” grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≀24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months β€” use filters for patent-cliff planning.

Page 125 of 173

  1. US 7833968

    Pharmaceutical compositions for treating or preventing bone conditions

    Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7829688

    Peptides of CaV2.2 that inhibit pain

    Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7829668

    Compositions and methods for modifying toxic effects of proteinaceous compounds

    Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7829279

    Compositions and methods for diagnosis and treatment of epilepsy

    Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7824697

    High concentration baclofen preparations

    Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7824680

    Methods for inhibiting angiogenesis

    Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7825278

    Substituted enaminones, their derivatives and uses thereof

    Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7825269

    Ligands for nematode nuclear receptors and uses thereof

    Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7825231

    Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain therapy

    Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7820663

    Substituted enaminones, their derivatives and uses thereof

    Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7820634

    Composition and method for production of transformed cells

    Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7820784

    Orally administered peptides synergize statin activity

    Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7815908

    Methods and compositions for treating and preventing disease associated with Ξ±VΞ²5 integrin

    Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7816086

    Genes of an otitis media isolate of nontypeable Haemophilus influenzae

    Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7816352

    Apoptosis inhibitors

    Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7816538

    Dimeric small molecule potentiators of apoptosis

    Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7816097

    Nucleotide and protein sequence of Mammastatin and methods of use

    Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7816131

    Cancer specific promoters

    Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7816324

    Composition and method for the treatment of diseases affected by a peptide receptor

    Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7811603

    Microfluidic device for forming monodisperse lipoplexes

    Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7811592

    Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia

    Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7812132

    Modified vitamin K-dependent polypeptides

    Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7811996

    Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection

    Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7811622

    Coated implantable medical device

    Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7807781

    Inhibitors of serine protease activity and their use in methods and compositions for treatment of viral infections

    Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7807787

    NELL-1 peptide

    Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7807644

    Chimeric proteins with phosphatidylserine binding domains

    Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7807651

    Methods and materials for pain management

    Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7807645

    Method of treating degenerative disorders of the nervous system by administration of fibrinogen fragment

    Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7807640

    Orally administered peptides synergize statin activity

    Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7807463

    Pre-transplant accommodated organs resistant to anti-donor immunity

    Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7807623

    Use of pentagastrin to inhibit gastric acid secretion or as a diuretic

    Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7807619

    Compositions and methods for modification of biomolecules

    Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7807618

    Methods and compositions for delivering enzymes and nucleic acid molecules to brain, bone and other tissues

    Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7807179

    Modified reoviral therapy

    Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7807383

    Diagnosing and treating hormone resistant cancers

    Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7807346

    High-throughput assay for virus entry and drug screening

    Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7803149

    Coated medical device

    Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7803363

    Attenuated Francisella bacteria

    Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7803558

    Modulation of aqueous humor outflow by targeting vascular-endothelial-cadherin in Schlemm's canal cells

    Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7803560

    Methods of screening for antagonists of mammalian monocyte chemoattractant protein receptors

    Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7803764

    Amphipathic glycopeptides

    Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7799518

    Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer

    Expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7799070

    Coated implantable medical device

    Expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7794726

    Mutants of lysine decarboxylase, vaccines for periodontitis, and methods of use

    Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7794728

    Attenuated Listeria spp. and methods for using the same

    Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7794957

    Eukaryotic genes involved in adult lifespan regulation

    Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7795495

    Transgenic mice for screening for inhibitors of protein aggregation and methods for making and using them

    Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.